Kilitch Drugs (India) standalone net profit rises 101.35% in the September 2018 quarter

Sales rise 78.73% to Rs 26.72 crore

Net profit of Kilitch Drugs (India) rose 101.35% to Rs 4.49 crore in the quarter ended September 2018 as against Rs 2.23 crore during the previous quarter ended September 2017. Sales rose 78.73% to Rs 26.72 crore in the quarter ended September 2018 as against Rs 14.95 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales26.7214.95 79 OPM %16.957.49 -PBDT6.422.69 139 PBT6.132.39 156 NP4.492.23 101

Powered by Capital Market - Live News